LDHA Rabbit Polyclonal Antibody
cat.: ER00702
Product Type: Rabbit polyclonal IgG, primary antibodies
Species reactivity: Human, Mouse, Rat
Applications: WB, IHC-P, FC
Clonality: Polyclonal
Form: Liquid
Storage condition: Store at +4℃ after thawing. Aliquot store at -20℃ or -80℃. Avoid repeated freeze / thaw cycles.
Storage buffer: 1*PBS (pH7.4), 0.2% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Concentration: 1 mg/mL.
Purification: Immunogen affinity purified.
Molecular weight: 37 kDa
Isotype: IgG
Immunogen: Synthetic peptide within Human LDHA aa1-50 / 332.
Positive control: Human tonsil tissue lysate, NIH/3T3 cell lysate, A549 cell lysate, Hela cell lysate, A431 cell lysate, 293 cell lysate, Jurkat cell lysate, MCF-7 cell lysate, human liver tissue lysate, human kidney tissue lysate, human brain tissue lysate, human thymus tissue lysate, rat liver tissue, rat skeletal muscle tissue, human liver tissue, human breast carcinoma tissue, mouse liver tissue.
Subcellular location: Cytoplasm.
Recommended Dilutions:
  WB
  IHC-P
  FC

1:500
1:200
1:100-1:200
Uniprot #: SwissProt: P00338 Human
Alternative names: Cell proliferation-inducing gene 19 protein GSD11 L lactate dehydrogenase A chain L-lactate dehydrogenase A chain l7R2 Lactate dehydrogenase 1, A chain Lactate dehydrogenase A Lactate dehydrogenase A4 Lactate dehydrogenase M LDH A LDH M LDH muscle subunit LDH muscle subunit; M LDH LDH-A LDH-M LDH1 ldha LDHA_HUMAN LDHM OTTMUSP00000017774 PIG19 Proliferation-inducing gene 19 Renal carcinoma antigen NY-REN-59
Images
ER00702_1.jpg Fig1: Western blot analysis of LDHA on different lysates. Proteins were transferred to a PVDF membrane and blocked with 5% BSA in PBS for 1 hour at room temperature. The primary antibody (ER00702, 1/500) was used in 5% BSA at room temperature for 2 hours. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1:200,000 dilution was used for 1 hour at room temperature.
Positive control:
Lane 1: Human tonsil tissue lysate
Lane 2: NIH/3T3 cell lysate
Positive control:
Lane 1: A549 cell lysate
Lane 2: Hela cell lysate
Lane 3: A431 cell lysate
Lane 4: 293 cell lysate
Lane 5: Jurkat cell lysate
Lane 6: MCF-7 cell lysate
Lane 7: Human liver tissue lysate
Lane 8: Human kidney tissue lysate
Lane 9: Human brain tissue lysate
Lane 10: Human thymus tissue lysate
ER00702_2.jpg Fig2: All lanes: Western blot analysis of LDHA with anti-LDHA antibody (ER00702) at 1:500 dilution.
Lane 1: Wild-type Hela whole cell lysate (10 µg).
Lane 2/3: LDHA knockdown Hela whole cell lysate (10 µg).

ER00702 was shown to specifically react with LDHA in wild-type Hela cells. Weakened bands were observed when LDHA knockdown samples were tested. Wild-type and LDHA knockdown samples were subjected to SDS-PAGE. Proteins were transferred to a PVDF membrane and blocked with 5% NFDM in TBST for 1 hour at room temperature. The primary antibody (ER00702, 1:500) was used in 5% BSA at room temperature for 2 hours. Goat Anti-Rabbit IgG-HRP Secondary Antibody (HA1001) at 1:300,000 dilution was used for 1 hour at room temperature.
ER00702_3.jpg Fig3: Immunohistochemical analysis of paraffin-embedded rat liver tissue using anti-LDHA antibody. The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes.The tissues were blocked in 1% BSA for 30 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ER00702, 1/50) for 30 minutes at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.
ER00702_4.jpg Fig4: Immunohistochemical analysis of paraffin-embedded rat skeletal muscle tissue using anti-LDHA antibody. The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes.The tissues were blocked in 1% BSA for 30 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ER00702, 1/50) for 30 minutes at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.
ER00702_5.jpg Fig5: Immunohistochemical analysis of paraffin-embedded human liver tissue using anti-LDHA antibody. The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes.The tissues were blocked in 1% BSA for 30 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ER00702, 1/50) for 30 minutes at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.
ER00702_6.jpg Fig6: Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue using anti-LDHA antibody. The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes.The tissues were blocked in 1% BSA for 30 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ER00702, 1/50) for 30 minutes at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.
ER00702_7.jpg Fig7: Immunohistochemical analysis of paraffin-embedded mouse liver tissue using anti-LDHA antibody. The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes.The tissues were blocked in 1% BSA for 30 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ER00702, 1/50) for 30 minutes at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.
Note: All products are “FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE”.